Literature DB >> 28628352

Characteristics of Hospitalized Cancer Patients Referred for Inpatient Palliative Care Consultation.

Joan D Penrod1,2, Melissa M Garrido1,2, Karen McKendrick2, Peter May3, Melissa D Aldridge2, Diane E Meier2, Katherine A Ornstein2, R Sean Morrison1,2.   

Abstract

BACKGROUND: Palliative care is associated with improved patient and family outcomes and lower cost of care, but studies estimate that <50% of hospitalized adults in the United States who are appropriate for palliative care receive it. Few studies have addressed demographic and clinical factors associated with receipt of palliative care.
OBJECTIVE: Our aim was to identify characteristics of hospitalized advanced cancer patients that are associated with referral to an interdisciplinary hospital-based palliative care team.
METHODS: The data are from a prospective observational study of hospitalized advanced cancer patients in five hospitals. We used multivariable logistic regression to estimate the relationship between patient characteristics and palliative care referral.
RESULTS: The sample includes 3096 patients; 81% received usual care and 19% were referred to palliative care. Advanced cancer patients were twice as likely to receive palliative care referral if, at admission, they needed assistance with transfer from bed (p = 0.002) and about 1.5 times as likely if they were taking medication for pain (p = 0.002), nausea (p = 0.04), or constipation (p = 0.04). Patients with more comorbidities (p = 0.001) and higher symptom burden (p = 0.001) were more likely to be referred.
CONCLUSION: Advanced cancer patients were more likely to be referred to the palliative care consultation team if they had high symptom burden at hospital admission. Overall a minority of advanced cancer patients were referred. Standardized screening for palliative care may be needed to ensure that advanced cancer patients receive the highest quality of evidence based care.

Entities:  

Keywords:  advanced cancer; hospital care; palliative care

Mesh:

Year:  2017        PMID: 28628352      PMCID: PMC5706623          DOI: 10.1089/jpm.2017.0111

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  36 in total

1.  Palliative care--a shifting paradigm.

Authors:  Amy S Kelley; Diane E Meier
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

2.  Factors associated with utilization of an inpatient palliative care consultation service in an urban public hospital.

Authors:  Pavan Bhatraju; Allison S Friedenberg; Amit Uppal; Laura Evans
Journal:  Am J Hosp Palliat Care       Date:  2013-08-28       Impact factor: 2.500

3.  Just good care? The palliative care of those with non-malignant disease.

Authors:  Miriam Johnson; Marie Fallon
Journal:  Palliat Med       Date:  2013-10       Impact factor: 4.762

Review 4.  Does palliative care improve outcomes for patients with incurable illness? A review of the evidence.

Authors:  Areej El-Jawahri; Joseph A Greer; Jennifer S Temel
Journal:  J Support Oncol       Date:  2011 May-Jun

5.  Multiple chronic conditions among Medicare beneficiaries: state-level variations in prevalence, utilization, and cost, 2011.

Authors:  Kimberly A Lochner; Richard A Goodman; Samual Posner; Anand Parekh
Journal:  Medicare Medicaid Res Rev       Date:  2013-07-23

6.  Bending the cost curve in cancer care.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

7.  The Prevalence of Inpatients at 33 U.S. Hospitals Appropriate for and Receiving Referral to Palliative Care.

Authors:  Marilyn K Szekendi; Jocelyn Vaughn; Ashima Lal; Kei Ouchi; Mark V Williams
Journal:  J Palliat Med       Date:  2016-01-20       Impact factor: 2.947

Review 8.  Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Betty R Ferrell; Jennifer S Temel; Sarah Temin; Erin R Alesi; Tracy A Balboni; Ethan M Basch; Janice I Firn; Judith A Paice; Jeffrey M Peppercorn; Tanyanika Phillips; Ellen L Stovall; Camilla Zimmermann; Thomas J Smith
Journal:  J Clin Oncol       Date:  2016-10-28       Impact factor: 44.544

9.  Palliative Care Teams' Cost-Saving Effect Is Larger For Cancer Patients With Higher Numbers Of Comorbidities.

Authors:  Peter May; Melissa M Garrido; J Brian Cassel; Amy S Kelley; Diane E Meier; Charles Normand; Lee Stefanis; Thomas J Smith; R Sean Morrison
Journal:  Health Aff (Millwood)       Date:  2016-01       Impact factor: 6.301

10.  Predictors of palliative care consultation on an inpatient gynecologic oncology service: are we following ASCO recommendations?

Authors:  Carolyn Lefkowits; Anna B Binstock; Madeleine Courtney-Brooks; Winifred G Teuteberg; Janet Leahy; Paniti Sukumvanich; Joseph L Kelley
Journal:  Gynecol Oncol       Date:  2014-03-01       Impact factor: 5.482

View more
  4 in total

1.  Factors related to satisfaction of cancer patients with transfer arrangements made by university hospitals at the end-of-life in Japan: a cross-sectional questionnaire survey of bereaved family members.

Authors:  Hiroko Ishimoto; Tokunori Ikeda; Yasuhiro Kadooka
Journal:  Support Care Cancer       Date:  2020-10-14       Impact factor: 3.603

2.  National trends in palliative care use among older adults with cardiopulmonary and malignant conditions.

Authors:  Shelli L Feder; Raymond A Jean; Lori Bastian; Kathleen M Akgün
Journal:  Heart Lung       Date:  2020-02-27       Impact factor: 2.210

3.  Evaluating Hospital Readmissions for Persons With Serious and Complex Illness: A Competing Risks Approach.

Authors:  Peter May; Melissa M Garrido; Egidio Del Fabbro; Danielle Noreika; Charles Normand; Nevena Skoro; J Brian Cassel
Journal:  Med Care Res Rev       Date:  2019-01-18       Impact factor: 2.971

4.  Factors Related to Family Caregivers' Readiness for the Hospital Discharge of Advanced Cancer Patients.

Authors:  Ru-Yu Huang; Ting-Ting Lee; Yi-Hsien Lin; Chieh-Yu Liu; Hsiu-Chun Wu; Shu-He Huang
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.